Combination of drug-eluting bead transarterial chemoembolization and PD-1 inhibitor for treatment of unresectable head and neck squamous cell carcinoma: an initial, short-term clinical experience in a single-center retrospective cohort study

IntroductionThis study investigated the clinical efficacy and safety of CalliSpheres® drug-eluting bead transarterial chemoembolization (DEB-TACE) combined with programmed death protein (PD)-1 inhibitors for treatment of unresectable head and neck squamous cell carcinoma (HNSCC).MethodsClinical data...

Повний опис

Бібліографічні деталі

Автори:	Bo Sun, Jin Qi Gao, Ruo Jie Li, Lei Song, Na Li, Fei Gao
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2025-07-01
Серія:	Frontiers in Immunology
Предмети:	camrelizumab drug-eluting CalliSpheres® -beads head and neck malignancies squamous cell carcinoma transarterial chemoembolization
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1615440/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!